7.28
price down icon1.22%   -0.09
pre-market  Pre-mercato:  7.06   -0.22   -3.02%
loading

Aura Biosciences Inc Azioni (AURA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
15.92%
17.05
20.28 15.43 15.12 14.40
Operating Income/Loss
9.97%
-22.31
-24.78 -20.49 -20.28 -19.44
Nonoperating Income/Loss
4.88%
2.653
2.789 1.976 1.977 1.978
Income/Loss From Continuing Operations Before Tax
10.61%
-19.66
-21.99 -18.51 -18.30 -17.47
Income Tax Expense/Benefit
0.046
- - - -
Income/Loss From Continuing Operations After Tax
10.96%
-19.71
-22.13 -18.51 -18.30 -17.47
Net Income/Loss
10.96%
-19.71
-22.13 -18.51 -18.30 -17.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,849%
49.45
1.6769 38.19 37.86 37.78
Diluted Average Shares
2,849%
49.45
1.6769 38.19 37.86 37.78
Basic Earnings Per Share
20.00%
-0.40
-0.50 -0.48 -0.48 -0.46
Diluted Earnings Per Share
20.00%
-0.40
-0.50 -0.48 -0.48 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Capitalizzazione:     |  Volume (24 ore):